![Joanna Lis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joanna Lis
Direttore/Membro del Consiglio presso International Society for Pharmacoeconomics & Outcomes Rsch
Profilo
Joanna Lis is currently working as a Director at the International Society for Pharmacoeconomics & Outcomes Research.
She has a graduate and doctorate degree from Uniwersytet Jagiellonski and an MBA from Kozminski University.
Posizioni attive di Joanna Lis
Società | Posizione | Inizio |
---|---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
![]() International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Direttore/Membro del Consiglio | - |
Formazione di Joanna Lis
Uniwersytet Jagiellonski | Doctorate Degree |
Kozminski University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
![]() International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Commercial Services |
- Borsa valori
- Insiders
- Joanna Lis